Methods and compositions for treating an angiotensinogen- (AGT-) associated disorder

ZA202504176BActive Publication Date: 2026-08-26ALNYLAM PHARMACEUTICALS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ZA202504176
Authority / Receiving Office: ZA · ZA
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2020-04-30
Filing Date: 2025-05-16
Publication Date: 2026-08-26
Estimated Expiration: 2045-05-16

Application Information

Patent Timeline

30 Apr 2020

Priority

16 May 2025

Application

ZA202504176

26 Aug 2026

Publication

ZA202504176B

IPC: A61K; C07H; C12N; A61P

Inventors: DONALD FOSTER; SAGAR AGARWAL

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to methods of inhibiting the expression of an AGT gene in a subject, as well as methods for treating subjects having an AGT-associated disorder, e.g., hypertension, using RNAi agents, e.g., double stranded RNAi agents, targeting the AGT gene. The invention also relates to methods of decreasing blood pressure levels in a subject using such RNAi agents to inhibit expression of an AGT gene.

Need to check novelty before this filing date? Find Prior Art